logo

For the Inventor, By the Inventor

Waltham, MA, United States of America

Praecis Pharmaceuticals, Inc.


USPTO Granted Patents = 43


Forward Citations = 961

Loading Chart...
Loading Chart...

59 inventors (with patents filed for the assignee):

goldMedal Malcolm L Gefter (24 out of 39 patents)

silverMedal Marc B Garnick (15 out of 18 patents)

bronzeMedal Mark A Findeis (14 out of 17 patents)

4.  Gary Fred Musso (13 out of 24 patents)

5.  Christopher C Arico-Muendel (12 out of 16 patents)

6.  Ethan R Signer (12 out of 12 patents)

7.  Christopher Self (11 out of 23 patents)

8.  Gary Olson (10 out of 30 patents)

9.  James Wakefield (10 out of 10 patents)

10.  Christopher J Molineaux (10 out of 11 patents)

11.  Jens Birktoft (9 out of 9 patents)

12.  Lily Lee (9 out of 12 patents)

13.  Charles Michael Cook (9 out of 14 patents)

14.  Kathryn Phillips (8 out of 12 patents)

15.  Barry A Morgan (8 out of 35 patents)


Core Competencies:
Encoded Libraries
Amyloid Peptide Aggregation
Sphingosine-1-Phosphate Receptor Agonists
Melanoma Treatment
Methionine Aminopeptidase-2 Inhibitors
Angiogenesis Modulation
Endometriosis Therapy
Sustained Drug Delivery
LHRH Antagonists
FGF Receptor Activity
Prostate Cancer Treatment
Peptide Binding Sequences

43 patents:

1. 7972992 - Methods for synthesis of encoded libraries (2011-07-05),
2. 7935658 - Methods for synthesis of encoded libraries (2011-05-03),
3. 7803774 - Modulators of β-amyloid peptide aggregation (2010-09-28),
4. 7759370 - Sphingosine-1-phosphate (SIP) receptor agonists (2010-07-20),
5. 7658917 - Modulators of amyloid aggregation (2010-02-09),
6. 7405194 - Therapeutic agents and methods of use thereof for the treatment of melanoma (2008-07-29),
7. 7348307 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2008-03-25),
8. 7268117 - Compositions, kits, and methods for identification, assessment, prevention, and therapy of endometriosis (2007-09-11),
9. 7268111 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-09-11),
10. 7241812 - Methods and compositions for modulating sphingosine-1-phosphate (S1P) receptor activity (2007-07-10),
11. 7175828 - Modulators of β-amyloid peptide aggregation comprising D-amino acids (2007-02-13),
12. 7157420 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2007-01-02),
13. 7109171 - Methods for treating FSH related conditions with GnRH antagonists (2006-09-19),
14. 7105482 - Methionine aminopeptidase-2 inhibitors and methods of use thereof (2006-09-12),
15. 7084108 - Therapeutic agents and methods of use thereof for the modulation of angiogenesis (2006-08-01),
Praecis Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of innovative therapies for cancer and other serious diseases. With a focus on precision medicine, Praecis is committed to advancing targeted treatments that improve patient outcomes and quality of life.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#29 in Waltham, MA

#452 in Massachusetts

#7,821 in US

#15,578 in the World

...
Waltham, MA, United States of America

Praecis Pharmaceuticals, Inc.

Forward Citations = 961

59 inventors:

goldMedal Malcolm L Gefter (24 out of 39 patents)

silverMedal Marc B Garnick (15 out of 18 patents)

bronzeMedal Mark A Findeis (14 out of 17 patents)

4.  Gary Fred Musso (13 out of 24 patents)

5.  Christopher C Arico-Muendel (12 out of 16 patents)

Please report any incorrect information to support@idiyas.com
Loading…